Aditi Gulati
Institute of Cancer Research(GB)Breast Cancer Now(GB)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, CRISPR and Genetic Engineering, Microtubule and mitosis dynamics, PARP inhibition in cancer therapy, DNA Repair Mechanisms
Most-Cited Works
- → ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A(2016)379 cited
- → Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance(2021)340 cited
- → Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival(2018)174 cited
- → Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer(2020)168 cited
- → E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer(2018)129 cited
- → HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer(2020)124 cited
- → Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines(2016)108 cited
- → Modeling Therapy Resistance in BRCA1/2 -Mutant Cancers(2017)86 cited
- → Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance(2022)82 cited
- → ATR Is a Therapeutic Target in Synovial Sarcoma(2017)60 cited